Stockreport

Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring [Yahoo! Finance]

Quanterix Corporation  (QTRX) 
US:NASDAQ Investor Relations: ir.quanterix.com/investor-relations
PDF Simoa technology paired with an extensive Simoa-derived normative data infrastructure enable individual patient interpretation, addressing a critical unmet need for ful [Read more]